Get Your Personalized Supplement StackSupplement Stack Quiz

Vaccinium Angustifolium

Also known as: Vaccinium angustifolium Aiton, Lowbush blueberry, wild blueberry, Vaccinium angustifolium

Overview

Vaccinium angustifolium, commonly known as lowbush or wild blueberry, is a North American native berry rich in polyphenols, particularly anthocyanins and flavonoids. It is utilized as a dietary supplement ingredient primarily for its potent antioxidant properties. Research suggests potential benefits in cardiovascular health, metabolic regulation, and cognitive function. While several clinical trials and systematic reviews broadly cover blueberry species, specific high-quality, large-scale randomized controlled trials (RCTs) focusing solely on V. angustifolium are still needed to solidify its evidence base. It is generally consumed for its health-promoting compounds and is available in various forms, including whole berries, juices, and extracts.

Benefits

V. angustifolium demonstrates strong antioxidant and anti-inflammatory effects due to its high polyphenol content. In vivo studies have shown anti-aging effects in model organisms and reductions in oxidative stress markers in humans, indicating its role in combating cellular damage. For cardiovascular health, clinical trials suggest a potential for blood pressure-lowering effects; one randomized controlled trial (RCT) with 20 participants observed a trend toward reduced systolic blood pressure with wild blueberry juice consumption, though the sample size was small. Regarding metabolic effects, meta-analyses including wild blueberry juice indicate no significant overall impact on fasting glucose and insulin levels, suggesting limited efficacy for glycemic control in healthy or prediabetic individuals. While related Vaccinium species have been studied for cognitive benefits, specific high-quality data on V. angustifolium's cognitive effects are currently sparse.

How it works

The primary mechanism of action for Vaccinium angustifolium involves its rich content of anthocyanins and other polyphenols. These compounds act as potent antioxidants by scavenging free radicals, thereby reducing oxidative stress throughout the body. They also modulate inflammatory pathways, contributing to their anti-inflammatory effects. These bioactive compounds may improve vascular function by enhancing endothelial function and reducing oxidative stress, which can contribute to the regulation of blood pressure. At a molecular level, they are thought to modulate gene expression related to oxidative stress and inflammation. The bioavailability of anthocyanins is moderate, and their systemic effects may be influenced by metabolism by gut microbiota.

Side effects

Vaccinium angustifolium and its extracts are generally considered safe, with no serious adverse effects reported in clinical trials at studied doses. Mild gastrointestinal discomfort, such as bloating or upset stomach, may rarely occur in sensitive individuals. There are no documented significant drug interactions or contraindications in the reviewed literature. However, specific safety data for special populations, such as pregnant or breastfeeding women and children, are lacking, and caution is advised in these groups. Individuals with known allergies to blueberries or other Vaccinium species should avoid this supplement. As with any supplement, it is recommended to consult a healthcare professional before starting, especially if you have pre-existing health conditions or are taking other medications.

Dosage

Clinical studies on Vaccinium angustifolium have utilized various dosages. For wild blueberry juice, doses of approximately 100 mL of 100% juice daily have been used, with some studies suggesting this amount may contribute to modest blood pressure reductions. For standardized polyphenol extracts, doses equivalent to several hundred milligrams of anthocyanins per day have been investigated. The minimum effective dose for specific benefits, such as blood pressure effects, appears to be around 100 mL of juice daily, but optimal dosing requires further research. Dosing timing is generally flexible, with chronic daily intake being typical in clinical trials. While absorption may be enhanced by co-ingestion with food, no specific cofactors are strictly required. It is important to adhere to product-specific recommendations or consult a healthcare professional for personalized guidance.

FAQs

Is V. angustifolium effective for blood sugar control?

Current evidence suggests minimal impact on fasting glucose or insulin levels in healthy or prediabetic individuals, indicating limited efficacy for blood sugar control.

Can it lower blood pressure?

Small randomized controlled trials show potential for modest reductions in blood pressure, but larger, more robust studies are needed to confirm this benefit definitively.

Are there cognitive benefits?

Evidence for specific cognitive benefits from V. angustifolium is limited and largely indirect, with more research needed to establish a clear link.

Is it safe for long-term use?

Yes, within the doses studied, V. angustifolium appears safe for long-term use, with no major safety concerns reported in clinical trials.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC7050746/ – This RCT investigated the effects of 100% wild blueberry juice on cardiovascular risk factors in 20 adults with prehypertension. It found a non-significant trend toward lower systolic blood pressure but no significant effect on glucose or insulin levels, highlighting the need for larger studies.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11695640/ – This review discusses the strong antioxidant capacity of Vaccinium species, including V. angustifolium, attributing it to anthocyanins. It notes preclinical evidence of anti-aging effects and potential anti-inflammatory benefits in humans, though primarily based on smaller studies.
https://onlinelibrary.wiley.com/doi/10.1002/ptr.70054 – This meta-analysis, which included studies on bilberry (a related Vaccinium species), found improvements in lipid profiles and reductions in inflammation markers. However, it reported limited effects on glycemic control, providing indirect insights into V. angustifolium's metabolic impact.